Cabaletta Bio Inc
NASDAQ:CABA

Watchlist Manager
Cabaletta Bio Inc Logo
Cabaletta Bio Inc
NASDAQ:CABA
Watchlist
Price: 2.21 USD 0.91% Market Closed
Market Cap: 212.8m USD

Net Margin
Cabaletta Bio Inc

0%
Current
0%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-158.5m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Cabaletta Bio Inc
Glance View

Market Cap
212.7m USD
Industry
Biotechnology

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania and currently employs 53 full-time employees. The company went IPO on 2019-10-25. The firm is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. The firm's lead CAAR T cell product candidate is designed based on chimeric antigen receptor (CAR), and its T cell technology has been developed and is marketed for the treatment of B cell cancers. The firm has discovered and developed four product candidates, including its lead product candidate, to potentially treat patients with mucosal pemphigus vulgaris (mPV), and three additional product candidates that have demonstrated specific and selective target engagement in vitro. Its product pipelines include DSG3-CAART, DSG3/1-CAART, Musk-CAART and FVIII-CAART.

CABA Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-158.5m
/
Revenue
0
What is the Net Margin of Cabaletta Bio Inc?

Based on Cabaletta Bio Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top